Showing 2421 results
- https://www.novartis.com/stories/women-science-jennifer-allport-anderson
- https://www.novartis.com/stories/young-talent-emerging-technologies-come-together-biocamp
- https://www.novartis.com/news/media-releases/sandoz-appoints-new-board-representative-global-amr-industry-allianceDr. Boumediene Soufi, global head of Sandoz AMR (antimicrobial resistance) program, to represent Sandoz as Board member of AMR Industry Alliance (AMRIA)The Alliance brings together about 100 life…
- https://www.novartis.com/stories/2-million-kids-receive-malaria-medicine
- https://www.novartis.com/stories/cancer-researchers-ready-aim-cures
- https://www.novartis.com/stories/women-science-wendy-winckler
- https://www.novartis.com/stories/women-science-marjorie-eiref
- https://www.novartis.com/stories/ai-changing-face-healthcare
- https://www.novartis.com/news/media-releases/fda-approves-novartis-kymriah-car-t-cell-therapy-adult-patients-relapsed-or-refractory-follicular-lymphoma68% of patients receiving Kymriah in the ELARA trial experienced complete response, with an 86% overall response rate, along with a remarkable safety profile1Sustained clinical benefit from Kymriah…
- https://www.novartis.com/stories/asian-health-experts-call-final-push-wipe-out-deadliest-form-malaria